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changes could explain the high preva-
lence of obstructive sleep apnea in Pompe 
patients (Margolis et al., 1994).
To conclude, Lee et al.’s (2011) observa-
tions raise the ante considerably concern-
ing the pathophysiology and treatment 
of Pompe disease. The evidence points 
to “double-trouble” for respiration. Not 
alone is there impairment in the physi-
ological function of the effector organs of 
the control system – the thoracic pump and 
airway dilator muscles whose co-ordinated 
activity is essential for effective pulmonary 
ventilation, but the spinal and brainstem 
motor systems that precisely control the 
effectors are also adversely affected. This 
coupled to the suggestion that respiratory 
rhythmogenesis and pattern generation 
are also perturbed, at least in mice, paints a 
devastating portrait of the “perfect storm” 
for breathing in Pompe disease. The major 
challenge is to overcome it. The paper by 
Lee et al. (2011) suggests that therapeutic 
strategies targeting the nervous system may 
be necessary to correct respiratory-related 
deficits in this devastating disease.
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extends to cranial motor neuronal pathways 
supplying key accessory muscles of respi-
ration. The findings of this well-executed, 
basic science investigation have significant 
implications for treatment strategies in gly-
cogen storage disease.
Using an established transgenic mouse 
model, Lee et al. (2011) tested the hypoth-
esis that systemic GAA deficiency results 
in glycogen accumulation in the cell 
bodies of motor neurons of the hypo-
glossal (XII) nucleus concomitant with 
impaired efferent respiratory neural 
discharge. Brainstem histology revealed 
widespread neuropathology as evidenced 
by extensive glycogen accumulation in 
neuronal cell bodies within the hypo-
glossal nucleus and other structures such 
as the nucleus ambiguus; PAS-positive 
reaction product was also identified in 
sustentacular cells of the medullary net-
work. Neurophysiological experiments in 
anesthetized mice revealed that compared 
to wild-type controls, Gaa−/− mice exhibit 
instability in neural circuits controlling 
respiratory timing, manifest as increased 
variability in respiratory motor output. 
Moreover, the authors observed a signifi-
cant decrease in integrated efferent traf-
fic (drive) to upper airway dilator muscles 
critical in the control and maintenance of 
pharyngeal airway caliber. The latter was 
revealed following bilateral vagotomy and 
removal of volume-related feedback inhi-
bition of respiratory motor output.
These novel observations concerning 
motor control of the upper airway in the 
Gaa−/− mouse raise intriguing questions 
concerning respiratory morbidity in Pompe 
disease. For example, is there a general 
blunting of spinal and cranial motor out-
flow in response to key respiratory-related 
cues to the central respiratory network such 
that airway mechanoreflex and airway and 
arterial chemoreflex recruitment of cra-
nial motor drive is depressed in Pompe 
patients? This has considerable clinical rel-
evance given that impaired neural control 
of the pharyngeal airway muscles increases 
the risk of airway obstructive events. Such 
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Glycogen storage disease type II (Pompe 
disease) results from a widespread defi-
ciency of acid α-glucosidase (GAA) – the 
lysosomal enzyme essential for glycogen 
breakdown. Defects in the GAA gene result 
in extensive glycogen accumulation in vis-
ceral organs and skeletal muscle, includ-
ing the striated muscles of respiration. 
Alas, respiratory insufficiency is common 
in Pompe patients (Mellies et al., 2005; 
Pellegrini et al., 2005; Mellies and Lofaso, 
2009), many of whom require ventilatory 
support (Haley et al., 2003; Marsden, 2005); 
indeed nearly one in five Pompe infants die 
of respiratory failure (Byrne et al., 2011). 
Muscle pathology has traditionally been 
implicated in motor perturbations in 
Pompe disease, but compelling evidence is 
accruing implicating nervous system distur-
bances in the pathophysiology of the disor-
der. Glycogen accumulation is observed in 
nervous tissues of patients (Mancall et al., 
1965; Gambetti et al., 1971; Martin et al., 
1973; Martini et al., 2001; Teng et al., 2004; 
DeRuisseau et al., 2009) and animal mod-
els (Matsui et al., 1983; Sidman et al., 2008; 
DeRuisseau et al., 2009) of the disease. Of 
relevance to respiratory control, phrenic 
motor neuron pathology is reported in 
the Gaa−/− mouse (DeRuisseau et al., 2009) 
and cervical spinal cord (DeRuisseau et al., 
2009) and brainstem (Mancall et al., 1965; 
Teng et al., 2004) pathology have been noted 
in Pompe patients postmortem. In this 
issue of Frontiers in Respiratory Physiology, 
Lee et al. (2011), explore further the res-
piratory phenotype of GAA-deficient mice 
providing evidence to suggest that respira-
tory perturbations in Pompe disease have 
a significant neurogenic component that 
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